Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Touru OGUMA
Pharmacological Profile of VP-343, a Novel Selective Vasopressin V2 Receptor Antagonist, in Rats.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Related publications
Histopathological Study of Kidney Abnormalities in an Experimental SIADH Rat Model and Its Application to the Evaluation of the Pharmacologic Profile of VP-343, a Selective Vasopressin V2 Receptor Antagonist.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Pharmacological Profile of TP-680, a New cholecystokininA Receptor Antagonist
British Journal of Pharmacology
Pharmacology
Arginine Vasopressin V1a Receptor Antagonist Impairs Maternal Memory in Rats
Physiology and Behavior
Philosophy
Behavioral Neuroscience
Experimental
Cognitive Psychology
The Vasopressin V2 Receptor Antagonists: The Vaptans
Global Journal of Endocrinological Metabolism
Acute Hemodynamic Effects of Conivaptan, a Dual V1A and V2 Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure
Circulation
Cardiovascular Medicine
Physiology
Cardiology
A Serine Cluster Prevents Recycling of the V2 Vasopressin Receptor
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Robalzotan (NAD-299), a Novel Selective 5-Ht 1A Receptor Antagonist
CNS Drug Reviews
In Vitro Pharmacological Properties of KRH-594, a Novel Angiotensin II Type 1 Receptor Antagonist.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
AE9C90CB: A Novel, Bladder-Selective Muscarinic Receptor Antagonist for the Treatment of Overactive Bladder
British Journal of Pharmacology
Pharmacology
